The BIT Pharma Management Team embraces industry leading experience in preclinical and clinical development, drug delivery technologies, as well as successful experience in general management.

Prof Dr Jörg Breitenbach

CEO of BIT Pharma. Retired head of global product development of Abbott Laboratories and former chairman of the supervisory board of Abbott GmbH, Germany . Elected Fellow of the American Institute for Medical and Biological Engineering. Publisher and author of an award winning book on the pharmaceutical industry, has published more than 50 peer reviewed articles and is inventor and coinventor to more than 60 patents. Member of the Editorial Board of the European Journal of Pharmaceutics and Biopharmaceutics. Advisory board member of start-up companies in Ireland and Germany. Professor at the university of Ludwigshafen, Germany, in the field of in health economics.

Prof Dr Peter Vajkoczy

Clinical Advisor of BIT Pharma. Director of the Neurosurgery Clinic and Polyclinic, Medical University Charité, Berlin and Associate Professor of Neurosurgery at the University of Heidelberg. Former Senior Physician at the Department of Neurosurgery, Mannheim University Hospital.

Dr Peter Hölig

Technology development expert of BIT Pharma. Head of Business Development at Lipoid GmbH. Former Senior Project Manager for Strategic Innovation, Health Care division at Evonik and Lab. Head for New Chemical Entities Formulation Science at AbbVie.

Dr Tiziana Adage

CSO of BIT Pharma. Former Head of Pharmacology at ProtAffin Biotechnologie AG and Extended Neuropharmacology Lab Head at MerckSerono.

Dr Doris Maier

CFO of BIT Pharma. Certified Auditor and Partner at Steirische Wirtschaftstreuhand. Former Director and Partner at PWC Austria.

Contact Us

Send us an email for further inquiry.

Not readable? Change text.